Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PS1 versus PF concurrent chemoradiotherapy for non-operable esophageal cancer
ChiCTR-TRC-11001492Phase 4Completed
- Sponsor
- Affiliated Cancer Hospital of Shantou University Medical College
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tegafur, cisplatin and fluorouracil in esophageal cancer (2 arms), sponsored by Affiliated Cancer Hospital of Shantou University Medical College. Primary endpoints: Progression-free survival and Short-term treatment effect. Started Oct 2011; status: completed.
02
Drugs
tegafurcisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR-TRC-11001492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001492.